Keros Therapeutics, Inc. - KROS

SEC FilingsOur KROS Tweets

About Gravity Analytica

Recent News

  • 02.06.2025 - Guggenheim SMID Cap Biotech Conference
  • 01.30.2025 - Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
  • 01.21.2025 - Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
  • 01.15.2025 - Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial

Recent Filings

  • 02.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 01.30.2025 - EX-99.1 EX-99.1
  • 01.30.2025 - 8-K Current report
  • 01.24.2025 - 4/A Statement of changes in beneficial ownership of securities